CGC logo

CGC Canopy Growth Corporation

NASDAQ Global Select · Drug Manufacturers - Specialty & Generic · Healthcare

$0.88
-0.01 (-0.79%)

Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divi…

Market Cap: $369.55Mwww.canopygrowth.com

Price

$0.97-0.39%
$0.89$0.92$0.95$0.97
Jul 9Aug 7

Social Signal Score

43
5d
30
1 mentions
+0.0%
30d
47
10 mentions
+0.0%
60d
46
13 mentions
+0.0%
90d
46
13 mentions
+0.5%
news: 13

Analyst Ratings

27 analysts
Holdconsensus
Strong Buy 0Buy 9Hold 11Sell 7Strong Sell 0
Avg price target$14.47+1553.0%
Low $8Median $11.02High $27.85
Current Consensus

Revenue

$81.17M+855.11%
$8.50M$56.51M$104.52M$152.53M
Sep 2016Jun 2026

Analyst Estimates

FY2026
$-0.33
$-0.35–$-0.31
3 analysts
FY2027
$-0.10
$-0.13–$-0.06
2 analysts
FY2028
$-0.08
$-0.10–$-0.06
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Luc Mongeau
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,128
Beta
2.41
Country
CA
Piotroski score
4 / 9 (Middling)
Altman Z-score
-13.41
www.canopygrowth.com